chrisvoncsefalvay/vaers-outcomes huggingface dataset:
breath are short; rash; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (breath are short) and RASH (rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included Transplant and Bipolar disorder.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced DYSPNOEA (breath are short) and RASH (rash). At the time of the report, DYSPNOEA (breath are short) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not provided. Treatment medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Non significant follow up: No new information was received
Pt received Recombivax 1cc IM (1st of two dose series) hep B vaccine-tolerated well. Apparently walked out of nurse's office at school where given and "faints" in hallway. She did not lose consciousness, but fell to floor without injuring herself brought to nurse's office in wheel chair by asst principal within minutes of event. States she feels "OK" OT 97.2 P 80 R 18 BP 120/70. Mother notified states child has fainted previously after receiving vaccines because "she is afraid of shots." Child rested in nurse's room until mother came to take her home. Mother and child to always tell practitioner her history before receiving shots. Suggested she receive 2nd hep B at PMD.
patient felt tingling on her face, mouth, palpitation gave 2 capsules of benadryl (total 50mg) Call 911 and went to emergency room
Patient was found to have increase in Creatinine from 0.82 on 2/12/21 to 1.31 on 3/26/21 noted on a blood draw done for routine labs only. He is currently being treated for likely glomerulonephritis ( pending w/up and biopsy) but is very sick in the ICU.  His Cr increased all the way to 4.  He has needed steroids for GN tx and this is all new for him.
FEELING "STRANGE, OR WEIRD..NOT MY "NORMAL FEELING" OF MYSELF...FELT THIS EFFECT THROUGH, SUNDAY, 1/10/2010. THIS FEELING OF "NOT BEING MYSELF, LED TO MOMENTARY CONFUSION, ON 1/08/2010,-12PM-2PM.
Vomiting, nausea, headache, sore throat, temp around 100. Began 18 or so hours after vaccination.
It was reported that a 33 year old male received Fluzone SV '98-'99 USP on 10/23/1998. Reportedly, 2 days, post vax, the pt experienced muscle aching, sore throat and fatigue lasting for 2 weeks.
Severe redness at injection site that lasted approximately 2 weeks.  Patient had pain and swelling and experience flu like symptoms.
Vaccinated [[name]] 07. URI in July 07. Onset weakness Aug 08. Inc sx in Sep to include numbness. Sought medical care. Dx with GBS and sx resolved with IVIG. Had recurrence of weakness again in Nov, and [[name]]. Dx changed to CIDP in [[name]]. Symptoms: Fever. Diagnosis 01/22/2008 Demyelinating polyneuritis, chronic inflammatory (357.81); 09/15/2007 Polyneuritis, acute infective (357.0)  11/14/08-records received-letter dated 5/21/08-recently diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). September 5 2007 presented with weakness in upper extremities prorgressed over next twelve days until September 17th when symptoms required  hospitalization. Initial diagnosis was Guillain [[name]] Syndrom but when his symptoms recurred [[name]]uary 2008 actually has CIDP.  1/20/09-records received for DOS 11/17/08 DC Summary peripheral neuropathy. Presented with progressive weakness in hands and feet. History of GBS this is second relapse. Refused LP.Discharge Summary for DOS 9/17-9/19/07-DC DX: muscle weakness. Guillaine [[name]]. presented with bilateral upper extremity weakness in hands and arms progressing over 3 weeks. Numbness and tingling of upper extremities. Horizontal nystagmus.  Tongue fasciculation. Treated with IVIG.
Pt received covid 19 vaccine appx 3 weeks prior to severe  Chest pain and elevated cardiac enzymes. Cardiologist notes believes to be myocarditis or pericarditis
Headache; Muscle ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the right arm on 04Feb2021 and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 01Mar2021 (both at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 04Feb2021, the patient experienced headache, muscle ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, muscle ache and fatigue was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a male patient of unknown age regarding himself. Patient's current condition and medical history was unknown. On 16-DEC-2014 the patient was vaccinated with ZOSTAVAX, subcutaneous. On 16-DEC-2014, ever since receiving the therapy with ZOSTAVAX, the patient experienced headache. The outcome of headache is unknown. Causality was not reported. Additional information has been requested.
About 2m after second COVID shot patient began feeling burning eyes and slight difficulty breathing. Paramedic onsite immediately listened to lungs and heard diffuse wheezing bilaterally. Within 1m minute patient felt throat tickling and then tightening and breathing was more difficult. Paramedic gave  patient EpiPen with resolution of symptoms in less than 1-2 minutes. Ambulance called and arrived very quickly. Patient was transported to  hospital. As way to hospital patient felt breathing getting worse again and was given solumedrol and benadryl IV and a second EpiPen. Don't yet know what happened beyond this.
PATIENT HAD VACCINE ON 04/09. ON 04/10 DEVELOPED A FEVER, COUGH AND SHORTNESS OF BREATH THAT GOT WORSE DURING THE DAY ALONG WITH SHARP SUBSTERNAL AND PRESSURE LIKE CHEST PAIN. ARRIVED TO ER ON 04/11@1851.
No adverse effects or symptoms following administration/No other AE; Caller is a medical assistant who reports VARIVAX was administered following temperature excursion.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. The patient's concomitant therapies included sterile diluent.  On 16-MAY-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot # U020244, expiration date 28-JUN-2023 (dose number, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). It was unknown if patient sought medical attention or received any treatment for the event. The vaccine underwent temperature excursion of 6 Fahrenheit degrees for 7 minutes on 15-MAY-2022. There was no previous temperature excursions. No other adverse event was reported (no adverse event).
Extremely heavy, painful, and long period that came 4 days early. I've never experienced such bad cramping and bleeding with a period before. I am not coming up on my next period and the terrible cramps have begun again. Prior to the vaccine I rarely had cramps, and if I did they were minor. Now I am having such strong cramps that I can only lay down with a heating pad. The bleeding is heavier and clots.
Narrative: presented to the ED on 4/30 for decreased PO intake for 2 days and altered mental status. He was recently discharged on 4/28 from hospital and treated for an aspiration pneumonia, thrush, and a UTI. On admission, pt was found to have thrush on admission and was started on IV fluconazole. His mental status initially improved on the IV fluconazole but it was transitioned to nystatin PO due to prolonged QTc. His mental status has waxed and waned. Neurology and psychiatry were consulted to assist with work- up. Neurology ordered a STAT Brain MRI due to sudden change in mental status on 5/7 from Ox2 to nonverbal and non following commands. It revealed abnormal signal around the third ventricle and mammilary bodies concerning for alcoholic encephalopathy and some fullness of his pituitary gland. he was not known to a be a heavy drinker
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1805031, expiry: 24-AUG-2021) dose was not reported, 1 total administered on 16-MAR-2021 to left arm around 1300 hours in the afternoon for prophylactic vaccination. No concomitant medications were reported. On 03-OCT-2021, patient had a confirmed positive breakthrough covid infection by  rapid test. The test was done at an urgent care at 0900 hours and he received the test results in the morning. They confirmed that he was positive for covid (suspected covid-19 infection) and hence also experienced a suspected clinical vaccination failure. The action taken with covid-19 vaccine was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  20211006768-Covid-19 vaccine - suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Menstrual cycle has been affected. 37 days late. No menstruation or even a single symptom of menstruation. Currently trying to conceive a baby but cannot track ovulation or menstrual cycle.
Expired Vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment  medications were reported. The vaccine was placed in refrigerator on 18-Nov-2021. The vial did not undergo any temperature excursion and patient did not experienced any adverse events.
Itchy, swollow, erythemous, warm injection site the day after vaccination. Unaware of any treatment. Symptoms subsided approximately 1-2 days after injection.
Patient complains of rash, throwing up, fever, chills, night sweats, dehydration, heart rate decrease, hospitalization in May for about a week.
anaphylaxis, requiring 3 epi pins, emergency transport, ER and inpatient treatment, 2 days hospitalization, pcp followup.; A 57-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 13Mar2021 10:00 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma and thyroid disorder. Concomitant medications included fluticasone; sodium propionate (PROPIONATE) and levothyroxine sodium. The patient previously took alatrofloxacin, pencillin, bactrim, levaquin and sulfa and experienced known allergies. The patient experienced anaphylaxis, requiring 3 epi pins, emergency transport, er and inpatient treatment, 2 days hospitalization, pcp followup on 13Mar2021 10:15. The patient was hospitalized for for 2 days on an unspecified date. Therapeutic measures were taken as a result of anaphylaxis included epinephrine, breathing treatments, speech therapy. Outcome of the event was unknown.
I had a bad headache for 4 days nothing would make it go away. I was lethargic and very tired. I had extreme lower back pain and it would radiate to the front of my body which also lasted about 4-5 days. I had a little bit of nasal congestion. I went to the urgent care and tested positive for COVID-19. I called my PCP Dr. and made and appointment and there was nothing he could do so he just advised me to rest. I have a follow up appointment with my heart doctor to have a stress test done next week because I am still tired feeling.
Initial information received on 12-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves female patient (age not reported) who experienced very hot to the touch, upper arm pain, upper arm itchy and whole upper arm swelling and redness, while she received vaccine FLUZONE QUADRIVALENT. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5 ml dose of suspect Influenza Quadrival A-B Vaccine lot number not reported via unknown route in unknown administration site. On an unknown date, the patient experienced a non-serious very hot to the touch (sensation of heat), upper arm pain (painful arm), upper arm itchy (pruritus) and whole upper arm swelling and redness (vaccination site inflammation) (Unknown latency) following the administration of Influenza Quadrival A-B Vaccine. Other relevant tests included no lab data. Final diagnosis was whole upper arm swelling and redness, upper arm itchy, upper arm pain and very hot to the touch. It was not reported if the patient received a corrective treatment. The patient outcome is not reported for all the events. List of documents held by sender: none.
Information has been received from a physician's assistant, via a company representative, concerning an 18 year old female patient, the daughter of one of her patients, who on an unspecified date was vaccinated with the first dose of Gardasil (lot # not reported).  The PA stated the patient had been a normal 18 year old, who immediately after the vaccination, "started acting very strange, almost like she was on drugs, depressed."  She added the patient "started to have mental illness, drug-like symptoms."  The patient was taken to a specialist, who told her she had abnormally high levels of aluminum in her body as a result of receiving the Gardasil.  The specialist felt that the symptoms were caused by the aluminum.  At the time of this report, the outcome of the events was not specified.  Additional information has been requested.
My arm has been sore ever since the injection. Just after midnight I got severe chills. After falling asleep I woke up at 4:00 am and vomited. I have had general body aches since then. Around 9:00 am I developed intermittent chest pain and tightness. As of 11:00 am I had a fever of 103°F.
Arm was sore for a few hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore for a few hours) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore for a few hours). At the time of the report, VACCINATION SITE PAIN (Arm was sore for a few hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported  The patient received the Moderna covid-19 vaccine in her right arm shoulder deltoid muscle.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Significant Follow up-Document attached, Reporter occupation, Vaccine Anatomical location, Dose 2 added & Event verbatim corrected.
Fever, chills, aches, muscle pain, joint pain, nausea, feeling unwell
Terrible pain in left arm; Sore throat; Runny nose; Grogginess; Lethargy; Fogginess; Wobbliness; Mild general achiness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 17:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as no chronic health conditions. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021, the patient experienced terrible pain in left arm, sore throat, runny nose, grogginess, lethargy, fogginess, wobbliness and mild general achiness. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events terrible pain in left arm, sore throat, runny nose, grogginess, lethargy, fogginess, wobbliness and mild general achiness was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I am a nurse practitioner and have received flu vaccines for many years. 2 weeks after receiving the flu vaccine in 2016, I developed a uveitis of the right eye and lost vision. I was referred to an uveitis specialist and PhD in immunology at Hospital by a local ophthalmologist. A paracentesis revealed Varicella Zoster Virus Retinitis. I was given antiviral injections in the eye on multiple occasions as well as oral antivirals and steroids. November 16, 2016 I had surgery that was initially planned to prevent retinal detachment, but the retina detached the night prior so the surgery was to correct that. I haven't been able to have a second surgery yet to remove the silicone oil to see if I have any vision left because of the inflammation behind the retina. I continue to be on eye drops (DUREZOL 8 times a day and Dorzolamide 3 times a day), Prednisone (since this started), and VALTREX (since this started).  This condition is high risk for developing in the other eye, therefore, I have been advised not to ever get another flu shot since we are not sure how my immune system will react. I will be on antivirals for the rest of my life, and I may never have vision in my right eye.
Left knee went out; Had trouble walking last night with right knee; Pain starting on the top of her head and moved down to her ear; Pain starting on the top of her head and moved down to her ear; A spontaneous report was received from a physician, concerning herself, a 70-year-old female patient, who received Moderna's Covid-19 vaccine (mRNA-1273) and experienced pain starting on the top of her head and it moved down to her ear/headache/ear pain, had trouble walking last night with right knee and left knee went out.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot # not provided) via unknown route in the left arm for prophylaxis of COVID-19 infection.   On an unspecified date, the patient noticed a pain starting on the top of her head and it moved down to her ear and she was unsure of when this started, It could have been before the vaccine or after. Additionally, patient had self-diagnosed herself with trigeminal neuralgia on the left side of her face. On 03 Jan 2021, she started having trouble with her right knee, but got better on the same night. On 04 Jan 2021, her left knee went out, but resolved quickly on the same date. Treatment for the event trigeminal neuralgia on left side of her face included acyclovir. No treatment information was provided for other events.  Action taken with mRNA-1273 in response to the events were not appplicable.   The outcome of event pain starting on the top of her head and it moved down to her ear/ headache was considered not resolved at the time of this report. The outcome of event pain starting on the top of her head and it moved down to her ear/ ear pain was considered resolved at the time of this report. The outcome of event trigeminal neuralgia on left side of her face and had trouble walking last night with right knee was resolved on 03 Jan 2021. The outcome of event left knee went out was resolved on 04 Jan 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Child was registered for 2nd dose of Pfizer covid vaccine for 12 and older and was given 0.3 ml of vaccine of the adult dose.  She apparently recieved the same dose for her intial dose given by another personnel as documented in her chart. I informed her parent while in observation of the error and monitored child foe effects. There was no visual problems and no complaints of adverse respones from child's mom. Charge nurse and clinical supervisor has been made aware
Flu like symptoms, fever 101.5, tired, "out of it", slight dry cough, First dose was 60 days prior. I think I MAY have been fine had I waited longer between injections and had the injection in the opposite arm from the initial injection.
3:45 PM heart started to race with a rate of 160, throat felt tight, arms heavy bilateral with numbness and tingling, elevated blood pressure 180/110.  I felt like I could run a race, but not move my arms and was nauseated.  I also ended up getting the shingles on 06/01/2021 after the Covid vaccine.
Patient stated she had a headache and felt like her blood pressure was high. Vital signs: BP 160/102, P 88, R 14, O2 96%. Head to toe assessment completed. Advised patient to stay for 15 minutes for monitoring. Patient did not want to stay for monitoring and left AMA.